PTPA and acute myeloid leukemia: Our current findings first revealed that EF-24 can attenuate the number of viable HL-60 FLT3-WT/NRAS (Q61L) AML cells through the induction of p38 MAPK-mediated apoptotic cell death via activating PP2A-mediated ERK deactivation.